Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)-Reference-Cited by-同舟云学术

Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)

Published:2018-12-04 Issue:1 Volume:142 Page:59-67
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Navarria Pierina^ORCID,Minniti Giuseppe,Clerici Elena,Tomatis Stefano,Pinzi Valentina,Ciammella Patrizia,Galaverni Marco,Amelio Dante,Scartoni Daniele,Scoccianti Silvia,Krengli Marco,Masini Laura,Draghini Lorena,Maranzano Ernesto,Borzillo Valentina,Muto Paolo,Ferrarese Fabio,Fariselli Laura,Livi Lorenzo,Pasqualetti Francesco,Fiorentino Alba,Alongi Filippo,di Monale Michela Buglione,Magrini Stefano,Scorsetti Marta

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-018-03059-x.pdf

Reference34 articles.

1. Wick W, Hartmann C, Engel C et al (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. J Clin Oncol 27(35):5874–5880

2. van den Bent M, Brandes A, Taphoorn M et al (2013) Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31(3):344–350

3. Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31(3):337–343

4. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

5. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459–466

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain Stem Glioma Recurrence: Exploring the Therapeutic Frontiers;Journal of Personalized Medicine;2024-08-25

2. What impact does therapy selection have on the course of clinical outcomes for recurrent gliomas?;MOJ Public Health;2024-06-03

3. Preferred Imaging for Target Volume Delineation for Radiotherapy of Recurrent Glioblastoma: A Literature Review of the Available Evidence;Journal of Personalized Medicine;2024-05-17

4. Treatment advances in high-grade gliomas;Frontiers in Oncology;2024-04-10

5. Validation of Combs prognostic scoring system in Indian recurrent glioma patients treated with re-radiation;Radiation Oncology Journal;2024-03-31